No such message found

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Eighth Positive Data Safety Monitoring Board Recommendation For Phase 3 Study of Apabetalone

Well, looks like all that talk (I am guilty) of not expecting the 8th DSMB report until dosing is complete was wrong. No worries. Another checkbox completed. Next up, hitting 250 events and end of dosing sometime in the next quarter. Hopefully more clarity on these timelines at Biotech Showcase on January 7.

BearDownAZ

Share
New Message
Please login to post a reply